Welcome
Elevate your Healthcare opportunity with DON
Assisting CEOs, Founders and sophisticated investors since 2024
Assisting CEOs, Founders and sophisticated investors since 2024
The Healthcare sector stand at the forefront of scientific innovation, offering the promise of groundbreaking therapies that can transform healthcare. However, the journey from concept to commercialization is fraught with challenges, and securing funding has never been more demanding especially for sophisticated investors.
At DON Healthcare, we recognize that networking is key to success in the dynamic world of healthcare. That's why our platform goes beyond just resources – it's a vibrant community where connections thrive, opportunities abound, and collaborations flourish.
Here's how Don Healthcare is transforming the landscape of healthcare networking:
1️. Connect with Industry Leaders: Join a diverse community of healthcare professionals, investors, and thought leaders. Forge meaningful connections, share insights, and stay at the forefront of industry trends.
2. Discover Potential Collaborators: Explore profiles of fellow Healthcare innovators and discover potential collaborators for your next project. Whether you're seeking expertise, funding, or strategic partnerships, DON makes it easy to find the right fit.
3. Virtual Events: Exchange ideas, seek advice, and gain invaluable perspectives from peers across the Healthcare spectrum during our virtual events.
4. Unlock Growth Opportunities: Networking isn't just about who you know – it's about what opportunities you uncover. From funding opportunities to new insights, DON Healthcare provides a gateway to growth and expansion your Healthcare ventures.
Join us at DON Healthcare and become part of a vibrant community, unlocking the full potential of your Healthcare endeavors.
At DON Healthcare, we strive to assist Healthcare companies by accessing our DON Monte Carlo HNW and UHNW Business network, we have a key focus on fundraising and general business development. Our team of experienced professionals is dedicated to helping you achieve your business goals and also access great business opportunities.
Our network consists of Billionaires, multi-millionaires, VCs, Funds, Private Banks, Service Providers, Professors, Scientists, Doctors and others. Business opportunities for sophisticated investors.
Sophisticated investors, decision makers, and opportunities are all brought together by this special online experience.
Due in part to COVID, we have welcomed over 1,500 virtual attendees since our launch in 2020.
A true meeting place for CEO's, Founders, decision makers and sophisticated investors.
We leverage AI to help clients streamline R&D, minimize costs, and uncover drug candidates taking them from lab to market faster and more safely than ever before.
We combine state-of-the-art technology, enormous amounts of data, and the best of human ingenuity to discover treatments for the most complex diseases.
ATRO Medical is founded with the objective to make a change through cooperation & perseverance. Our innovations contribute to preservation of the knee joint. These new treatment options need to be accessible for both surgeons and patients. Therefore, we’re ahead in contact with insurances before the product is available on the shelf.
Cancer Research and Biotechnology AG is a Swiss preclinical oncology company focusing on metabolic diseases and mitochondrial healing for cancer treatments. CRB is developing new-generation cancer treatments that selectively eradicate cancer cells without inducing toxicity.
Mermaid Bio’s Intrabodies represent a novel precision-medicine approach that can tackle notoriously difficult targets and is piloted directly to the tissue of interest to avoid damaging side effects.
NKILT Therapeutics is a new cell therapy biotech developing a novel approach to engineering immune cells, starting with natural killer (NK) cells, to directly target leukemias and solid tumors.
Preci-HealthTM is revolutionizing the landscape of medical care by providing accessible, safe and virtually painless solutions for blood sampling and injections – anytime, anywhere. Our vision is to ensure every individual has the tools needed to manage their health with unprecedented accuracy and ease – ultimately, leading to informed decision making and improved healthcare outcomes.
Proud to announce that we are now working with J.P Morgan Life Sciences Private Capital Fund I.
Biotechnology Venture Capital Fund with over $500 million in Commitments
Proud to announce that we are now working with M Ventures
M Ventures is the strategic, corporate venture capital fund of Merck, investing in Biotechnology and Technology. We cover the areas of Healthcare drug development, Life Science tools, Electronics and Frontier Technology & Sustainability.
600 million euros Fund
1/6
Elite speaker at DON Healthcare Investment Dinner held on the 26th of April at Le Meridien Beach Plaza Hotel Monaco.
Was a guest speaker at DON Healthcare Investment Dinner held on the 26th of April at Le Meridien Beach Plaza Hotel Monaco.
NUAgo is developing single construct short RNAs that kill tumor cells selectively as a therapy for treatment resistant cancers.
Was a guest speaker at DON Healthcare Investment Dinner held on the 26th of April at Le Meridien Beach Plaza Hotel Monaco.
NUAgo is developing single construct short RNAs that kill tumor cells selectively as a therapy for treatment resistant cancers.
Copyright © 2024 DON Therapeutics - All Rights Reserved.
DON THERAPEUTICS LTD is not a Registered Investment Advisor, Broker/Dealer, Financial Analyst, Financial Bank, Securities Broker or Financial Planner. The Information on this 1. Company email, 2 Company Site, 3 Company LinkedIn is provided for information purposes only. The Information is not intended to be and does not constitute financial advice or any other advice, is general in nature and not specific to you. Before using the Company’s information to make an investment decision, you should seek the advice of a qualified and registered securities professional and undertake your own due diligence. None of the information on our email, website, or LinkedIn is intended as investment advice, as an offer or solicitation of an offer to buy or sell, or as a recommendation, endorsement, or sponsorship of any security, Company, or fund. The Company is not responsible for any investment decision made by you. You are responsible for your own investment research and investment decisions.
Powered by DON Therapeutics